BDBM362236 2,5-Dimethyl-1-(2-phenyl-thiazol-4-ylmethyl)-1H-pyrrole-3-carboxylic acid-4-((S)-1-amino-ethyl)-benzylamide::US9834513, 51

SMILES C[C@H](N)c1ccc(CNC(=O)c2cc(C)n(Cc3csc(n3)-c3ccccc3)c2C)cc1

InChI Key InChIKey=IQRYOMJGXFGGCX-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 362236   

TargetPlasma kallikrein(Human)
Kalvista Pharmceuticals

US Patent
LigandPNGBDBM362236(US9834513, 51 | 2,5-Dimethyl-1-(2-phenyl-thiazol-4...)
Affinity DataIC50: 341nMAssay Description:Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2019
Entry Details
US Patent

TargetKallikrein-1(Human)
Kalvista Pharmceuticals

US Patent
LigandPNGBDBM362236(US9834513, 51 | 2,5-Dimethyl-1-(2-phenyl-thiazol-4...)
Affinity DataIC50: 1.00E+4nMAssay Description:KLK1 inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2019
Entry Details
US Patent